Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3210-3214

  Hu, Wei Gang ^a   Chau, Damon ^a   Wu, Josh ^a   Jager, Scott ^a   Nagata, Les P ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Antibody; Humanization; Venezuelan equine encephalitis virus

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; MURINE MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN PURIFICATION; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DRUG SYNTHESIS; EMBRYO; ENCEPHALOMYELITIS; GENE; HEAVY CHAIN; HUMAN; HUMAN CELL; LIGHT CHAIN; PRIORITY JOURNAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

EID: 33947719377     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.034     Document Type: Article

References (13)

1. Weaver S.C., Ferro C., Barrera R., Boshell J., and Navarro J.C. Venezuelan equine encephalitis. Annu Rev Entomol 49 (2004) 141-174
2. Rivas F., Diaz L.A., Cardenas V.M., Daza E., Bruzon L., Alcala A., et al. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis 175 (1997) 828-832
3. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., and Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14 (1996) 337-343
4. Jahrling P.B., and Stephenson E.H. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol 19 (1984) 429-431
5. France J.K., Wyrick B.C., and Trent D.W. Biochemical and antigenic comparison of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains. J Gen Virol 44 (1979) 725-740
6. Roehrig J.T., Day J.W., and Kinney R.M. Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118 (1982) 269-278
7. Roehrig J.T., and Mathews J.H. The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142 (1985) 347-356
8. Schroff R.W., Foon K.A., Beatty S.M., Oldham R.K., and Morgan Jr. A.C. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45 (1985) 879-885
9. Verhoeyen M., Milstein C., and Winter G. Reshaping human antibodies: grafting an antilysozyme activity. Science 239 (1988) 1534-1536
10. Dall'Acqua W.F., Damschroder M.M., Zhang J., Woods R.M., Widjaja L., Yu J., et al. Antibody humanization by framework shuffling. Methods 36 (2005) 43-60
11. Hu W.G., Alvi A.Z., Fulton R.E., Suresh M.R., and Nagata L.P. Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to Venezuelan equine encephalitis virus. Hybrid Hybridomics 21 (2002) 415-420
12. Hwang W.Y., Almagro J.C., Buss T.N., Tan P., and Foote J. Use of human germline genes in a CDR homology-based approach to antibody humanization. Methods 36 (2005) 35-42
13. van den Ouweland A.M., van Duijnhoven H.L., Keizer G.D., Dorssers L.C., and Van de Ven W.J. Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast KEX2. Nucleic Acids Res 18 (1990) 664